Tag: bioequivalence

Jan, 7 2026
Derek Hoyle 5 Comments

How the FDA Ensures Generic Drug Safety Through Manufacturing Oversight

The FDA ensures generic drug safety through strict manufacturing standards, inspections, and ongoing surveillance. Every generic must match the brand-name drug in effectiveness and safety, with oversight continuing long after approval.

View more
Dec, 21 2025
Derek Hoyle 13 Comments

Quality by Design in Generic Drug Development: Modern Science-Based Approaches

Quality by Design (QbD) is now the standard for generic drug development, replacing outdated testing methods with science-based process control. Learn how QbD improves bioequivalence, cuts approval times, and saves millions-while ensuring consistent, safe medicines.

View more